Filing Details
- Accession Number:
- 0001104659-17-031830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-11 12:17:27
- Reporting Period:
- 2017-05-08
- Filing Date:
- 2017-05-11
- Accepted Time:
- 2017-05-11 12:17:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626199 | Nivalis Therapeutics Inc. | NVLS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184334 | E Robert Conway | C/O Nivalis Therapeutics, Inc. Po Box 18387 Boulder CO 80308 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-08 | 15,000 | $2.28 | 60,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price recorded in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.244 to $2.329, inclusive. The reporting person undertakes to provide Nivalis Therapeutics, Inc., any security holder of Nivalis Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
